Previous studies have confirmed that patients with late-onset AD (LOAD) have higher peripheral blood TREM2 mRNA levels than those with early-onset AD (EOAD), suggesting that this differential expression is linked to age rather than AD disease status (Guven et al., 2020). The gene discussed is TREM2; the disease is Alzheimer disease.